invivodata's ePRO Solution Captures Primary Efficacy Data Supporting Supplemental Approval of Sucampo's AMITIZA for a ... (Centre Daily Times)
invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that its ePRO solutions -- DiaryPRO(R) and SitePRO(R) -- captured primary efficacy data that supported the recent U.S. Food and Drug Administration's (FDA) supplemental approval of Sucampo Pharmaceutical Inc.'s AMITIZA(R) (lubiprostone) 8 mcg ...

I-Flow To Present At The Bank of America 2008 Health Care Conference on Tuesday, May 13, 2008 at 11:20 a.m. PDT (Centre Daily Times)
I-FLOW CORPORATION (NASDAQ:IFLO) announced today that it will address institutional shareholders at the Bank of America 2008 Health Care Conference on Tuesday morning, May 13, 2008 at 11:20 a.m. PDT.